These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34773568)

  • 21. Evidence for Cerebral Embolic Prevention in Transcatheter Aortic Valve Implantation and Thoracic Endovascular Aortic Repair.
    Lam HT; Kwong JM; Lam PL; Yeung WL; Chan YC
    Ann Vasc Surg; 2019 Feb; 55():292-306. PubMed ID: 30218830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral embolic protection devices during transcatheter aortic valve implantation, the current state of the art.
    Deveci OS; Okutucu S; Fatihoglu SG; Oto A
    Acta Cardiol; 2022 May; 77(3):196-203. PubMed ID: 33827380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of routine use of a cerebral protection device on the TAVR procedure and its short-term outcomes: a single-centre experience.
    von Kemp MJ; Floré V; Lau CW; De Sutter J; Provenier F; Cornelis K
    Acta Cardiol; 2022 Dec; 77(10):922-929. PubMed ID: 36044035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral protection devices during transcatheter aortic valve implantation.
    Vlastra W; Vendrik J; Koch KT; Baan J; Piek JJ; Delewi R
    Trends Cardiovasc Med; 2018 Aug; 28(6):412-418. PubMed ID: 29428159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
    Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TriGuard
    Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral Embolic Protection and Stroke-Related Mortality Following Transcatheter Aortic Valve Replacement.
    Isogai T; Bansal A; Vanguru HR; Agrawal A; Shekhar S; Puri R; Reed GW; Krishnaswamy A; Uchino K; Kapadia SR
    JACC Cardiovasc Interv; 2022 Mar; 15(5):569-571. PubMed ID: 35272784
    [No Abstract]   [Full Text] [Related]  

  • 28. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement.
    Yashima F; Briasoulis A; Kuno T; Noguchi M; Ahmad H; Zaid S; Goldberg JB; Malik AH; Tang GHL
    Cardiovasc Revasc Med; 2022 Mar; 36():9-13. PubMed ID: 34024747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral Embolic Protection Devices for Transcatheter Aortic Valve Replacement: Review of the Literature and Future Perspectives.
    Ng S; Cunningham T; Vavalle JP
    Curr Cardiol Rep; 2024 May; 26(5):339-347. PubMed ID: 38472629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the future role of cerebral embolic protection in transcatheter aortic valve implantation?
    Sondergaard L; Mylotte D; Capodanno D
    EuroIntervention; 2022 Oct; 18(8):e617-e619. PubMed ID: 36205735
    [No Abstract]   [Full Text] [Related]  

  • 31. Early Clinical Impact of Cerebral Embolic Protection in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Kroon HG; van der Werf HW; Hoeks SE; van Gils L; van den Berge FR; El Faquir N; Rahhab Z; Daemen J; Poelman J; Schurer RAJ; van den Heuvel A; de Jaegere P; van der Harst P; Van Mieghem NM
    Circ Cardiovasc Interv; 2019 Jun; 12(6):e007605. PubMed ID: 31195822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First-in-human study of the CAPTIS embolic protection system during transcatheter aortic valve replacement.
    Danenberg H; Vaknin-Assa H; Makkar R; Virmani R; Manevich L; Codner P; Patel V; Finn AV; Landes U; Rubinshtein R; Bar A; Barnea R; Mezape Y; Teichman E; Eli S; Weisz G; Kornowski R
    EuroIntervention; 2023 Dec; 19(11):e948-e952. PubMed ID: 37916296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.
    Baumbach A; Mullen M; Brickman AM; Aggarwal SK; Pietras CG; Forrest JK; Hildick-Smith D; Meller SM; Gambone L; den Heijer P; Margolis P; Voros S; Lansky AJ
    EuroIntervention; 2015 May; 11(1):75-84. PubMed ID: 25868876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral Embolic Protection in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Clinical Trials.
    Al-Abcha A; Saleh Y; Abbasi M; El-Am E; Alkhouli M
    Am J Cardiol; 2023 Jan; 187():179-180. PubMed ID: 36396481
    [No Abstract]   [Full Text] [Related]  

  • 35. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
    Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Van Gils L; Kroon H; Daemen J; Ren C; Maugenest AM; Schipper M; De Jaegere PP; Van Mieghem NM
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):790-797. PubMed ID: 28895285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Experience With Embolic Protection Devices During Transcatheter Aortic Valve Replacement.
    Stamou SC; Polcari K; Abdallah A; James T; Rothenberg M; Daniel G; Nores MA
    J Invasive Cardiol; 2019 Oct; 31(10):296-299. PubMed ID: 31567113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT II.
    Nazif TM; Moses J; Sharma R; Dhoble A; Rovin J; Brown D; Horwitz P; Makkar R; Stoler R; Forrest J; Messé S; Dickerman S; Brennan J; Zivadinov R; Dwyer MG; Lansky AJ;
    JACC Cardiovasc Interv; 2021 Mar; 14(5):515-527. PubMed ID: 33663779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Judgment Reserved: The Evolving Development of Cerebral Embolic Protection Devices in Transcutaneous Aortic Valve Replacement.
    Cormican DS
    J Cardiothorac Vasc Anesth; 2023 Feb; 37(2):195-197. PubMed ID: 36460562
    [No Abstract]   [Full Text] [Related]  

  • 40. Cerebral Embolic Protection in Valve-in-Valve Transcatheter Aortic Valve Replacement.
    Shekhar S; Krishnaswamy A; Reed G; Puri R; Yun J; Kapadia S
    Am J Cardiol; 2024 Apr; 216():110-111. PubMed ID: 38402923
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.